BC Cancer, part of the Provincial Health Services Authority
$110,220.00 CAD
≈ 17 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- July 13, 2020 – February 2, 2023
- Reference
- nrc-cnrc:172-2022-2023-Q2-953930
Published purpose
The main goal of this work is to create a made-in-Canada clinical ready approach for genome editing of CAR-T for cancer immunotherapy. The project aims to enhance the potency of single-domain antibody (sdAb) targeted CAR-Ts being developed by the Cell and Gene Therapy program, through site specific integration into rationally selected gene loci under conditions that are conducive to GMP CAR-T manufacture.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions